Brief: Lineage Cell Reports Additional Retinal Tissue Restoration Cases In Dry AMD Patients Treated With Opregen RPE Cells

Lineage Cell Therapeutics

01/06/2021 11:57

June 1 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS ADDITIONAL CASES OF
RETINAL
TISSUE RESTORATION IN DRY AMD PATIENTS TREATED WITH OPREGEN® RPE
CELLS
    * LINEAGE CELL THERAPEUTICS INC - RESTORATION WAS OBSERVED
IN TWO
ADDITIONAL PATIENTS IN A PHASE 1/2A CLINICAL STUDY OF OPREGEN
    * LINEAGE CELL THERAPEUTICS INC - RESTORATION HAS BEEN
OBSERVED IN
THREE OF FOUR PATIENTS WHO RECEIVED OPREGEN RPE CELLS ACROSS A
WIDE AREA OF ATROPHY
    * LINEAGE CELL THERAPEUTICS INC - OVERALL, OPREGEN HAS BEEN
WELL
TOLERATED WITH NO UNEXPECTED ADVERSE EVENTS OR SERIOUS ADVERSE
EVENTS

Source text for Eikon:  ID:nBw1HPhJHa 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))